nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—SLC6A2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00602	0.00602	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—ELOVL4—age related macular degeneration	0.00596	0.00596	CbGpPWpGaD
Clomipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—RHO—age related macular degeneration	0.00589	0.00589	CbGpPWpGaD
Clomipramine—CYP1A2—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00562	0.00562	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00555	0.00555	CbGpPWpGaD
Clomipramine—SLC6A2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00537	0.00537	CbGpPWpGaD
Clomipramine—SLC6A2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00537	0.00537	CbGpPWpGaD
Clomipramine—ALB—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00531	0.00531	CbGpPWpGaD
Clomipramine—ALB—Vitamin B12 Metabolism—CRP—age related macular degeneration	0.00523	0.00523	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—F13B—age related macular degeneration	0.00521	0.00521	CbGpPWpGaD
Clomipramine—ALB—Lipid and lipoprotein metabolism—APOE—age related macular degeneration	0.0052	0.0052	CbGpPWpGaD
Clomipramine—ALB—Vitamin B12 Metabolism—APOE—age related macular degeneration	0.00512	0.00512	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00505	0.00505	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—SERPING1—age related macular degeneration	0.0049	0.0049	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—RHO—age related macular degeneration	0.00487	0.00487	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—RHO—age related macular degeneration	0.00486	0.00486	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—SLC16A8—age related macular degeneration	0.00481	0.00481	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—RHO—age related macular degeneration	0.00442	0.00442	CbGpPWpGaD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00441	0.00441	CbGpPWpGaD
Clomipramine—ALB—Vitamin B12 Metabolism—CCL2—age related macular degeneration	0.0043	0.0043	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—RDH8—age related macular degeneration	0.00426	0.00426	CbGpPWpGaD
Clomipramine—ALB—Folate Metabolism—CRP—age related macular degeneration	0.00425	0.00425	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—RAD51B—age related macular degeneration	0.00425	0.00425	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—RHO—age related macular degeneration	0.00422	0.00422	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—F13B—age related macular degeneration	0.00411	0.00411	CbGpPWpGaD
Clomipramine—ALB—Platelet degranulation—CD36—age related macular degeneration	0.00405	0.00405	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—SLC16A8—age related macular degeneration	0.00395	0.00395	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—SERPING1—age related macular degeneration	0.00387	0.00387	CbGpPWpGaD
Clomipramine—ALB—Response to elevated platelet cytosolic Ca2+—CD36—age related macular degeneration	0.00385	0.00385	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—RHO—age related macular degeneration	0.00384	0.00384	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—RHO—age related macular degeneration	0.00373	0.00373	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—RPE65—age related macular degeneration	0.00372	0.00372	CbGpPWpGaD
Clomipramine—HRH2—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00366	0.00366	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00352	0.00352	CbGpPWpGaD
Clomipramine—ALB—Folate Metabolism—CCL2—age related macular degeneration	0.0035	0.0035	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—RHO—age related macular degeneration	0.00341	0.00341	CbGpPWpGaD
Clomipramine—ABCB1—Allograft Rejection—C3—age related macular degeneration	0.00339	0.00339	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—RHO—age related macular degeneration	0.00339	0.00339	CbGpPWpGaD
Clomipramine—ALB—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00338	0.00338	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—RAD51B—age related macular degeneration	0.00335	0.00335	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—RDH8—age related macular degeneration	0.00327	0.00327	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00324	0.00324	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00316	0.00316	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—SLC16A8—age related macular degeneration	0.00312	0.00312	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—RHO—age related macular degeneration	0.00309	0.00309	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00303	0.00303	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—ABCA4—age related macular degeneration	0.003	0.003	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—RDH8—age related macular degeneration	0.00298	0.00298	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.00291	0.00291	CbGpPWpGaD
Clomipramine—HRH2—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00286	0.00286	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—RPE65—age related macular degeneration	0.00285	0.00285	CbGpPWpGaD
Clomipramine—GSTP1—Cellular responses to stress—VEGFA—age related macular degeneration	0.00282	0.00282	CbGpPWpGaD
Clomipramine—HTR6—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.0028	0.0028	CbGpPWpGaD
Clomipramine—HRH2—GPCR ligand binding—C3—age related macular degeneration	0.00278	0.00278	CbGpPWpGaD
Clomipramine—ALB—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00278	0.00278	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—RHO—age related macular degeneration	0.00275	0.00275	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.0027	0.0027	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.0027	0.0027	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00265	0.00265	CbGpPWpGaD
Clomipramine—SLC6A2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00265	0.00265	CbGpPWpGaD
Clomipramine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00261	0.00261	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—RHO—age related macular degeneration	0.00261	0.00261	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—RPE65—age related macular degeneration	0.00261	0.00261	CbGpPWpGaD
Clomipramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00256	0.00256	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—RHO—age related macular degeneration	0.0025	0.0025	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00246	0.00246	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—LIPC—age related macular degeneration	0.00246	0.00246	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RDH8—age related macular degeneration	0.00241	0.00241	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—RHO—age related macular degeneration	0.00239	0.00239	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—CETP—age related macular degeneration	0.00237	0.00237	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00236	0.00236	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00236	0.00236	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—ABCA4—age related macular degeneration	0.0023	0.0023	CbGpPWpGaD
Clomipramine—ADRA2A—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00227	0.00227	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—NMNAT1—age related macular degeneration	0.00227	0.00227	CbGpPWpGaD
Clomipramine—HTR6—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00219	0.00219	CbGpPWpGaD
Clomipramine—HRH2—GPCR ligand binding—CCL2—age related macular degeneration	0.00218	0.00218	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—RHO—age related macular degeneration	0.00217	0.00217	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—RHO—age related macular degeneration	0.00217	0.00217	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—C3—age related macular degeneration	0.00214	0.00214	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RPE65—age related macular degeneration	0.0021	0.0021	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—ABCA4—age related macular degeneration	0.0021	0.0021	CbGpPWpGaD
Clomipramine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.0021	0.0021	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RDH8—age related macular degeneration	0.00209	0.00209	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00206	0.00206	CbGpPWpGaD
Clomipramine—ADRA2A—G alpha (i) signalling events—C3—age related macular degeneration	0.00205	0.00205	CbGpPWpGaD
Clomipramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.002	0.002	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—RHO—age related macular degeneration	0.002	0.002	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ELOVL4—age related macular degeneration	0.00199	0.00199	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—RHO—age related macular degeneration	0.00197	0.00197	CbGpPWpGaD
Clomipramine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.00197	0.00197	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—C3—age related macular degeneration	0.00195	0.00195	CbGpPWpGaD
Clomipramine—ALB—Platelet degranulation—VEGFA—age related macular degeneration	0.00193	0.00193	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RDH8—age related macular degeneration	0.0019	0.0019	CbGpPWpGaD
Clomipramine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	0.00184	0.00184	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—RHO—age related macular degeneration	0.00183	0.00183	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RPE65—age related macular degeneration	0.00183	0.00183	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00179	0.00179	CbGpPWpGaD
Clomipramine—ALB—Metabolism—NMNAT1—age related macular degeneration	0.00179	0.00179	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00179	0.00179	CbGpPWpGaD
Clomipramine—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.00171	0.00171	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ABCA4—age related macular degeneration	0.00169	0.00169	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—CCL2—age related macular degeneration	0.00167	0.00167	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RPE65—age related macular degeneration	0.00166	0.00166	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00163	0.00163	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—NMNAT1—age related macular degeneration	0.00161	0.00161	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—SLC16A8—age related macular degeneration	0.0016	0.0016	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—C3—age related macular degeneration	0.00157	0.00157	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00157	0.00157	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—C3—age related macular degeneration	0.00157	0.00157	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.00157	0.00157	CbGpPWpGaD
Clomipramine—ALB—Metabolism—ELOVL4—age related macular degeneration	0.00157	0.00157	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—CCL2—age related macular degeneration	0.00153	0.00153	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	0.00148	0.00148	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—RHO—age related macular degeneration	0.00147	0.00147	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ABCA4—age related macular degeneration	0.00147	0.00147	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TGFBR1—age related macular degeneration	0.00147	0.00147	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00145	0.00145	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—C3—age related macular degeneration	0.00143	0.00143	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—CD36—age related macular degeneration	0.00143	0.00143	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ELOVL4—age related macular degeneration	0.00141	0.00141	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—C3—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ABCA4—age related macular degeneration	0.00134	0.00134	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00133	0.00133	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—SQSTM1—age related macular degeneration	0.00133	0.00133	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.0013	0.0013	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—RHO—age related macular degeneration	0.00128	0.00128	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00128	0.00128	CbGpPWpGaD
Clomipramine—ALB—Metabolism—SLC16A8—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Clomipramine—GSTP1—Metabolism—APOE—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—NMNAT1—age related macular degeneration	0.00125	0.00125	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—C3—age related macular degeneration	0.00124	0.00124	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—CCL2—age related macular degeneration	0.00123	0.00123	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—C3—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—CD36—age related macular degeneration	0.00117	0.00117	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00117	0.00117	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—RHO—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—SLC16A8—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TGFBR1—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—CCL2—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—C3—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ELOVL4—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—C3—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Clomipramine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—CCL2—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TGFBR1—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—SQSTM1—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—C3—age related macular degeneration	0.001	0.001	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00098	0.00098	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—CCL2—age related macular degeneration	0.000972	0.000972	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000968	0.000968	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—SQSTM1—age related macular degeneration	0.00093	0.00093	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—CD36—age related macular degeneration	0.000925	0.000925	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—C3—age related macular degeneration	0.000889	0.000889	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—SLC16A8—age related macular degeneration	0.000884	0.000884	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—CCL2—age related macular degeneration	0.000857	0.000857	CbGpPWpGaD
Clomipramine—ALB—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000855	0.000855	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000846	0.000846	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—C3—age related macular degeneration	0.000844	0.000844	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000842	0.000842	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000841	0.000841	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TGFBR1—age related macular degeneration	0.000828	0.000828	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—LIPC—age related macular degeneration	0.00082	0.00082	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—C3—age related macular degeneration	0.000807	0.000807	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CETP—age related macular degeneration	0.000791	0.000791	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—APOE—age related macular degeneration	0.000786	0.000786	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—CCL2—age related macular degeneration	0.000783	0.000783	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—C3—age related macular degeneration	0.000772	0.000772	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—KDR—age related macular degeneration	0.00077	0.00077	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000756	0.000756	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—SQSTM1—age related macular degeneration	0.00075	0.00075	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000743	0.000743	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000719	0.000719	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—C3—age related macular degeneration	0.000702	0.000702	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—C3—age related macular degeneration	0.000701	0.000701	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000682	0.000682	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000667	0.000667	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CCL2—age related macular degeneration	0.00066	0.00066	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000654	0.000654	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000652	0.000652	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—C3—age related macular degeneration	0.000647	0.000647	CbGpPWpGaD
Clomipramine—ALB—Metabolism—LIPC—age related macular degeneration	0.000647	0.000647	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—C3—age related macular degeneration	0.000637	0.000637	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—CCL2—age related macular degeneration	0.000631	0.000631	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CETP—age related macular degeneration	0.000624	0.000624	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—APOE—age related macular degeneration	0.000603	0.000603	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000593	0.000593	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—C3—age related macular degeneration	0.000591	0.000591	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—KDR—age related macular degeneration	0.00059	0.00059	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000589	0.000589	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—LIPC—age related macular degeneration	0.000581	0.000581	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—LIPC—age related macular degeneration	0.000567	0.000567	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CETP—age related macular degeneration	0.00056	0.00056	CbGpPWpGaD
Clomipramine—ADRA2A—Hemostasis—VEGFA—age related macular degeneration	0.000558	0.000558	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—APOE—age related macular degeneration	0.00055	0.00055	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000548	0.000548	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CETP—age related macular degeneration	0.000547	0.000547	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—KDR—age related macular degeneration	0.000539	0.000539	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—LIPC—age related macular degeneration	0.000534	0.000534	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00052	0.00052	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CETP—age related macular degeneration	0.000515	0.000515	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CCL2—age related macular degeneration	0.000506	0.000506	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000499	0.000499	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—C3—age related macular degeneration	0.000477	0.000477	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CD36—age related macular degeneration	0.000475	0.000475	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CCL2—age related macular degeneration	0.000462	0.000462	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—LIPC—age related macular degeneration	0.000452	0.000452	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—APOE—age related macular degeneration	0.000444	0.000444	CbGpPWpGaD
Clomipramine—ALB—Hemostasis—VEGFA—age related macular degeneration	0.00044	0.00044	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CETP—age related macular degeneration	0.000437	0.000437	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—KDR—age related macular degeneration	0.000435	0.000435	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—VEGFA—age related macular degeneration	0.000424	0.000424	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—APOE—age related macular degeneration	0.000419	0.000419	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—C3—age related macular degeneration	0.000414	0.000414	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—APOE—age related macular degeneration	0.000385	0.000385	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—KDR—age related macular degeneration	0.000378	0.000378	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—C3—age related macular degeneration	0.000377	0.000377	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CD36—age related macular degeneration	0.000375	0.000375	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CCL2—age related macular degeneration	0.000373	0.000373	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APOE—age related macular degeneration	0.000351	0.000351	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000349	0.000349	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—KDR—age related macular degeneration	0.000343	0.000343	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CETP—age related macular degeneration	0.000337	0.000337	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CD36—age related macular degeneration	0.000337	0.000337	CbGpPWpGaD
Clomipramine—ALB—Metabolism—APOE—age related macular degeneration	0.000331	0.000331	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CD36—age related macular degeneration	0.000329	0.000329	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—VEGFA—age related macular degeneration	0.000325	0.000325	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CCL2—age related macular degeneration	0.000324	0.000324	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CD36—age related macular degeneration	0.00031	0.00031	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—APOE—age related macular degeneration	0.000297	0.000297	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—VEGFA—age related macular degeneration	0.000297	0.000297	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CCL2—age related macular degeneration	0.000295	0.000295	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—APOE—age related macular degeneration	0.00029	0.00029	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—APOE—age related macular degeneration	0.000273	0.000273	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CD36—age related macular degeneration	0.000262	0.000262	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—VEGFA—age related macular degeneration	0.00024	0.00024	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—APOE—age related macular degeneration	0.000231	0.000231	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000208	0.000208	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CD36—age related macular degeneration	0.000202	0.000202	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000189	0.000189	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—APOE—age related macular degeneration	0.000179	0.000179	CbGpPWpGaD
